Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q1 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $172 thousand.

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.